Home > Healthcare & Medical Devices > Enteric Disease Testing Market
Enteric Disease Testing Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032
- Report ID: GMI4024
Enteric Disease Testing Market size is expected to grow significantly from 2023 to 2032 due to the rising sales of frozen foods and ready-to-eat meals. Enteric diseases refer to intestinal illnesses caused by bacteria, viruses, parasites, and other microorganisms. This kind of illness can spread from person to person and is typically brought on by consuming tainted food or drink. Typically, gastrointestinal pathogen panels are used to screen for the presence of bacteria, parasites, and viruses that cause disease in stool samples.
The global burden of morbidity and mortality, including cognitive impairment among individuals affected with enteric infections like norovirus, is expected to increase significantly in the coming years. The industry revenue will increase even more due to the intense focus on the creation of affordable therapies to lessen enteric disease infections in low- and middle-income nations.
As per the testing method, the molecular diagnostic testing method will contribute to a larger enteric disease testing market revenue by 2032. This can be attributed to the quick advancement of real-time, high-throughput PCR technologies for the identification of bacterial and viral enteric illnesses. The strong demand for genomic and genetic data has prompted the proliferation of molecular diagnostic alternatives throughout the healthcare spectrum.
Regionally, the North America enteric disease testing market is expected to record considerable expansion by 2032. Typhoid fever is becoming more common in the United States, and it is typically brought on by foreign travel. Each year, the typhoid Salmonella virus infects close to 500 people in the nation. This element will increase the need for enteric infection treatment and testing in the area, together with the nation's strong emphasis on the monitoring, investigation, and prevention of foodborne diseases.
Cepheid Inc. (Danaher Corporation), Trinity Biotech, Biomerica, Meridian Bioscience, Coris Bioconcept SPRL, Bio-Rad Laboratories, DiaSorin, Quest Diagnostics, Biomerieux SA (Institut Mérieux, Sofina), and Alere are a few of the prominent companies operating in the global enteric disease testing industry.
The Russia-Ukraine war may impact the enteric disease testing market as supply chain, trade cycle, and raw material availability have been hampered due to the war. The manufacturers in the market are looking for new suppliers to connect with and drive market growth. In the coming years, new product developments using new supplies are expected to drive the industry expansion.
What Information does this report contain?
